Boundless Bio (BOLD) vs iBio (IBIO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Boundless Bio (BOLD) has outperformed iBio (IBIO) over the past year, gaining 114.6% versus a gain of 16.1%. iBio is the larger company by market cap ($59.2 million vs $58.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BOLD | IBIO |
|---|---|---|
| Share price | $2.58 | $0.92 |
| Market cap | $58.69M | $59.16M |
| 1-day change | -2.27% | -8.91% |
| YTD return | +120.00% | -47.67% |
| 1-year return | +114.63% | +16.09% |
| 5-year return | — | -99.78% |
| EPS (TTM) | $-2.85 | $-0.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.16 | $3.82 |
| 52-week low | $0.961 | $0.78 |
| Distance from 52-week high | -18.46% | -75.92% |
| Average volume | 179.14K | 735.37K |
| Shares outstanding | 22.75M | 64.31M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BOLD has outperformed IBIO by 98.5 percentage points over the past year.
BOLD vs IBIO FAQ
Which is bigger, Boundless Bio or iBio?
iBio (IBIO) is larger, with a market capitalization of $59.16M compared with $58.69M for Boundless Bio (BOLD).
Which stock has performed better over the past year, BOLD or IBIO?
BOLD returned +114.63% over the past 12 months, compared with +16.09% for IBIO (price return, excluding dividends). Past performance does not predict future results.
Are Boundless Bio and iBio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.